[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)]

Cardiologia. 1996 Aug;41(8):739-45.
[Article in Italian]
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Adrenergic beta-Antagonists / therapeutic use*
  • Anti-Arrhythmia Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Isoproterenol / therapeutic use
  • Male
  • Myocardial Infarction / drug therapy*
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / physiopathology
  • Propranolol / therapeutic use
  • Sotalol / therapeutic use*
  • Survival Rate
  • Ventricular Fibrillation / drug therapy

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Propranolol
  • Sotalol
  • Isoproterenol